Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
ACS Applied Polymer Materials|January 17, 2024
Solubilizing Benzodifuranone-Based Conjugated Copolymers with Single-Oxygen-Containing Branched Side ChainsDiego R Hinojosa, Nathan J Pataki, Pietro Rossi, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2014
TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trialAndreas Erhardt, Frank Kolligs, Matthias Dollinger, et al.
Hepatology (Baltimore, Md.)|May 29, 2009
Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphataseErwin Daniel Brenndörfer, Juliane Karthe, Lars Frelin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 21, 2021
Clinical effectiveness of bidirectional fecal microbiota transfer in the treatment of recurrent Clostridioides difficile infectionsChristian Bestfater, Maria J G T Vehreschild, Andreas Stallmach, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 7, 2013
Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis deltaGökhan Kabaçam, Heiner Wedemeyer, Berna Savaş, et al.
Gastrointestinal Endoscopy|January 18, 2019
Endoscopic full-thickness resection for early colorectal cancerArmin Kuellmer, Julius Mueller, Karel Caca, et al.
The New England Journal of Medicine|January 28, 2011
Peginterferon plus adefovir versus either drug alone for hepatitis deltaHeiner Wedemeyer, Cihan Yurdaydìn, George N Dalekos, et al.
Antiviral Therapy|February 2, 2012
Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatmentIngmar Mederacke, Cihan Yurdaydin, George N Dalekos, et al.
Gastroenterology|November 3, 2004
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patientsHolger Hinrichsen, Yves Benhamou, Heiner Wedemeyer, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|November 20, 2012
Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitisGökhan Kabaçam, George N Dalekos, Yılmaz Çakaloğlu, et al.
Pageof 8